James Lind Care is pleased to announce that Rasmus Hjorth, Patient Engagement Director, will participate as a panelist at the 24th BioPharma Clinical Trials Nexus 2025. He will take part in the high-profile session, “Future of Patient Centricity: Disrupting Pharma’s Outdated Clinical Trials for a Better 2030.”
The BioPharma Clinical Trials Nexus is an exclusive, invitation-only forum that brings together senior clinical trial executives, leading suppliers, and innovative solution providers to address the most pressing challenges in clinical development. The conference’s curated program highlights practical, forward-looking strategies and real-world case studies from trailblazers who are reshaping how clinical research is conducted.
In the panel session, Rasmus Hjorth will join fellow industry leaders to explore how patient centricity must evolve to meet the needs of tomorrow’s clinical ecosystem. Topics will include reimagining trial design and recruitment, leveraging digital health and decentralized study models, improving participant experience and retention, and aligning regulatory and sponsor priorities to make trials more accessible, equitable, and efficient by 2030.